needed effects
dipyridamole
active ingredient
persantine
unwanted side effects
medical attention
following side effects
taking dipyridamole
check
doctor
nurse
dipyridamole side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
oral administration of dipyridamole
active ingredient
persantine
adverse effects during intravenous
administration
patients
majority of dipyridamole-induced adverse effects
administration
intravenous aminophylline
cardiovascular symptoms
reported adverse effects
dipyridamole
active ingredient
persantine
ischemia
angina
been reported following
been reported following oral administration
intravenous administration
chest pain
st segment depression
facial flushing
severe ischemia
atrial
ventricular premature beats
ventricular tachycardia
ventricular fibrillation
bradycardia
asystole
sinus arrest
myocardial infarction
hypotension
average decrease in mean arterial pressure
chest pain
ischemia
myocardial infarction
dipyridamole
phenomenon
shunting of blood flow
ischemic area
diseased vessels
non-diseased areas
dipyridamole administration
vasodilation
myocardial infarction
patients with unstable angina
aminophylline
adenosine-receptor antagonist
effects of dipyridamole
including chest pain
bronchospasm
intravenous aminophylline
myocardial imaging
nervous system effects
occurred following
oral administration of dipyridamole
active ingredient
persantine
headache
lightheadedness
dizziness
paresthesias
cerebrovascular accident
following intravenous administration
case report
patient with asthma
sudden bronchospasm
wheezing
coughing
dyspnea
receiving
dipyridamole
active ingredient
persantine
thallium stress testing
symptoms
hypoxemia
minutes after administration
aminophylline
respiratory tract
adverse effects
patients with pre-existing asthma
chronic obstructive pulmonary disease
dyspnea
bronchospasm
respiratory arrest
gastrointestinal disturbances
dipyridamole
active ingredient
persantine
therapy
nausea
vomiting
patients
gallstones
containing dipyridamole
patients on long-term dipyridamole therapy
hematologic abnormalities
rare bleeding complications
platelet
inhibitory effects of dipyridamole
active ingredient
persantine
small study
dipyridamole
active ingredient
persantine
reversible reduction in glomerular filtration rate in patients with elevated renin-angiotensin activity
ascites
cirrhosis
sodium
free water excretion
hypersensitivity reactions
angioedema
anaphylaxis
side effects of persantine
fda
healthcare professional for medical advice
chest pain
gallstones
tightness
swelling of neck
yellow eyes
skin
stomach cramps
diarrhea 
dizziness or lightheadedness
flushing
headache
nausea or vomiting
weakness
general discomfort
unusual tiredness
weakness
hair loss
joint pain
swelling
muscle pain
runny nose
sneezing